跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 65,202 条关于
“ADAPT-2”
全部
65,202
临床试验
42,305
药物
7,325
机构
1,387
资讯
14,185
去年
Handok Gains Korean Approval for Doptelet to Treat ITP and CLD-Related Thrombocytopenia
2个月前
WHO Marks 25 Years of Research4Life: Expanding Equitable Access to Scientific Knowledge Across 120 Countries
12个月前
TGF-β Inhibitor Pipeline Expands with 25+ Companies Developing Novel Therapies for Cancer and Fibrosis
去年
Lebrikizumab Shows Promise in Atopic Dermatitis, Including After Dupilumab Discontinuation
4个月前
Creative Medical Technology Reports 93% Response Rate for Ultrasome™ in Knee Osteoarthritis Pilot Study
去年
AdAPT-001, EpicentRx's Oncolytic Virus-Delivered TGFβ Inhibitor, Receives FDA Fast Track Designation for Soft Tissue Sarcoma
去年
IRA Impact: CDMOs Adapt to Navigate Small Molecule Drug Development Challenges
2年前
UAB Launches ADAPT Trial: Adaptive Treatment for Early Smoking Cessation Relapse
去年
Regulators Adapt to AI Revolution in Healthcare: MHRA Leads with New Guidance and Sandbox Initiative
去年
EU Clinical Trial Regulation Transition: Sponsors Adapt as Deadline Looms
第 1 页,共 1419 页
上一页
下一页